183 related articles for article (PubMed ID: 16796648)
1. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL).
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
[TBL] [Abstract][Full Text] [Related]
2. Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
Balachandran I; Walker JW; Broman J
Diagn Cytopathol; 2010 Mar; 38(3):213-6. PubMed ID: 19774614
[TBL] [Abstract][Full Text] [Related]
3. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
[TBL] [Abstract][Full Text] [Related]
4. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
[TBL] [Abstract][Full Text] [Related]
5. Solitary CD30+ anaplastic large cell lymphoma of the eyelid showing regression.
Winhoven SM; Murugesan S; Coulson IH
Br J Ophthalmol; 2005 Mar; 89(3):385. PubMed ID: 15722323
[No Abstract] [Full Text] [Related]
6. Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL).
Massimino M; Spreafico F; Luksch R; Giardini R
Med Pediatr Oncol; 2001 Aug; 37(2):97-102. PubMed ID: 11496346
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.
Laurent C; Do C; Gascoyne RD; Lamant L; Ysebaert L; Laurent G; Delsol G; Brousset P
J Clin Oncol; 2009 Sep; 27(25):4211-6. PubMed ID: 19636007
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
Bonvini P; Gastaldi T; Falini B; Rosolen A
Cancer Res; 2002 Mar; 62(5):1559-66. PubMed ID: 11888936
[TBL] [Abstract][Full Text] [Related]
9. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
Hsu FY; Johnston PB; Burke KA; Zhao Y
Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
[TBL] [Abstract][Full Text] [Related]
10. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
Weisenburger DD; Anderson JR; Diebold J; Gascoyne RD; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Armitage JO
Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases.
Kesler MV; Paranjape GS; Asplund SL; McKenna RW; Jamal S; Kroft SH
Am J Clin Pathol; 2007 Aug; 128(2):314-22. PubMed ID: 17638668
[TBL] [Abstract][Full Text] [Related]
12. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
13. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
Rudzki Z; Rucińska M; Jurczak W; Skotnicki AB; Maramorosz-Kurianowicz M; Mruk A; Piróg K; Utych G; Bodzioch P; Srebro-Stariczyk M; Włodarska I; Stachura J
Pol J Pathol; 2005; 56(1):37-45. PubMed ID: 15921012
[TBL] [Abstract][Full Text] [Related]
14. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
15. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
16. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
17. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature.
Grewal JS; Smith LB; Winegarden JD; Krauss JC; Tworek JA; Schnitzer B
Ann Hematol; 2007 Jul; 86(7):499-508. PubMed ID: 17396261
[TBL] [Abstract][Full Text] [Related]
18. Multiple-cytokine-producing CD30-positive diffuse large B-cell lymphoma.
Nakayama-Ichiyama S; Yokote T; Oka S; Iwaki K; Kobayashi K; Akioka T; Hiraoka N; Takayama A; Takubo T; Tsuji M; Hanafusa T
Leuk Res; 2010 Jul; 34(7):e164-6. PubMed ID: 20167370
[No Abstract] [Full Text] [Related]
19. Anaplastic Large Cell Lymphoma.
Medeiros LJ; Elenitoba-Johnson KS
Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30 positive anaplastic large cell lymphoma in an adolescent.
Vaid R; Cohen B
Pediatr Dermatol; 2009; 26(6):721-4. PubMed ID: 20199449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
